Watershed Informatics

Bioinformatics platform for multi-omics data analysis

Cambridge, Massachusetts, United States

About Watershed Informatics

Watershed Informatics operates in the bioinformatics field, providing a platform designed for the analysis of multi-omics data, which includes various biological data types. This platform is tailored for researchers and biologists in academic institutions, pharmaceutical companies, and biotech firms. Users can quickly generate insights and create publication-quality figures without needing extensive coding skills. The company follows a subscription-based model, allowing clients to access its platform and features for a fee. Additionally, Watershed offers services like custom workflow development and data science consulting. What sets Watershed apart from its competitors is its commitment to being an active partner in the research process, enabling clients to concentrate on their innovative discoveries by utilizing Watershed's infrastructure and expertise in data science.

Cambridge, MassachusettsHeadquarters
2020Year Founded
$15.8MTotal Funding
SERIES_ACompany Stage
Data & Analytics, BiotechnologyIndustries
11-50Employees

Risks

Emerging competition from AI-driven platforms may reduce Watershed's market share.
Rapid tech advancements could make current tools obsolete without updates.
Economic downturns might affect subscription renewals from key clients.

Differentiation

Watershed offers bioinformatics tools with minimal coding required for researchers.
The platform supports multi-omics data analysis, including transcriptomics and proteomics.
Watershed's subscription model provides cost-effective access to advanced bioinformatics tools.

Upsides

Growing demand for AI-driven bioinformatics tools boosts Watershed's market potential.
Interest in single-cell RNA sequencing aligns with Watershed's platform capabilities.
Increased academic and biotech collaborations expand Watershed's customer base.

Funding

Total raised$15.76 M
Latest valuation$72.50 M
StageSERIES_A
$2
$8.50 M